Payment of Cash Dividend

22 January 2021

BEXIMCO PHARMACEUTICALS LIMITED

Payment of Cash Dividend

Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces that the 15% cash dividend of the nominal value per ordinary share/GDR (Taka 1.50 per ordinary share/GDR) for the year ended 30 June 2020, which was approved in the Annual General Meeting ("AGM") held on 19 December 2020, has been deposited with the custodian bank in Dhaka on 17 January 2021 for onward credit to respective GDR holders' accounts.

For any queries regarding the credit of dividend to respective accounts of holders of GDRs, please contact the Depository (The Bank of New York Mellon) representative, Mr. Vinu Kurian, at [email protected].

For further information please visit www.beximcopharma.com or enquire to:

Notes to Editors

About Beximco Pharmaceuticals Limited

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Since its inception in 1976, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines. Company's broad portfolio of generics encompasses diverse delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, insulins, prefilled syringes, injectables, nebuliser solutions, oral soluble films etc. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies.

Beximco Pharma′s state-of-the-art manufacturing facilities are certified by global regulatory authorities of USA, Europe, Australia, Canada, GCC and Latin America, among others and it has a geographic footprint in more than 50 countries. More than 5,500 employees are driving the company towards achieving its aspiration to be among the most admired companies in the world.